أرسل هذا في رسالة قصيرة: Health-related quality-of-life in a randomized phase III first-line study of gefitinib versus carboplatin/paclitaxel in clinically selected patients from Asia with advanced NSCLC (IPASS)

 __   _      ___      _  __    _____     ______  
| || | ||   / _ \\   | |/ //  |  ___||  /_____// 
| '--' ||  / //\ \\  | ' //   | ||__    `____ `  
| .--. || |  ___  || | . \\   | ||__    /___//   
|_|| |_|| |_||  |_|| |_|\_\\  |_____||  `__ `    
`-`  `-`  `-`   `-`  `-` --`  `-----`   /_//     
                                        `-`